Exhaled nitric oxide levels in children with non-cystic fibrosis bronchiectasis in New Zealand

E. A. Edwards, C. Douglas, S. Broome, W. Ferguson, J. Kolbe, C. Byrnes (Auckland, New Zealand)

Source: Annual Congress 2002 - Miscellaneous respiratory infections in children
Session: Miscellaneous respiratory infections in children
Session type: Thematic Poster Session
Number: 2106
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. A. Edwards, C. Douglas, S. Broome, W. Ferguson, J. Kolbe, C. Byrnes (Auckland, New Zealand). Exhaled nitric oxide levels in children with non-cystic fibrosis bronchiectasis in New Zealand. Eur Respir J 2002; 20: Suppl. 38, 2106

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Fractional exhaled nitric oxide levels in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016


Exhaled nitric oxide is not reduced in infants with cystic fibrosis
Source: Eur Respir J 2006; 27: 350-354
Year: 2006



Differences in exhaled nitric oxide levels between patients with cystic fibrosis and atopic bronchial asthma
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013


Reduced exhaled nitric oxide in infants with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment
Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018
Year: 2019



Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004

Airway acidification and exhaled nitric oxide in cystic fibrosis
Source: Eur Respir J 2003; 22: Suppl. 45, 514s
Year: 2003

Airway nitric oxide production in patients with cystic fibrosis increases with ivacaftor therapy
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


Orally and nasally exhaled nitric oxide and nitrite in asthmatic and cystic fibrosis patients
Source: Eur Respir J 2003; 22: Suppl. 45, 131s
Year: 2003

Exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease
Source: International Congress 2017 – ILDs: clinical problems
Year: 2017

Fractional exhaled nitric oxide in infants with bronchopulmonary dysplasia, cystic fibrosis and recurrent wheezing
Source: Eur Respir J 2005; 26: Suppl. 49, 674s
Year: 2005

Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005


Exhaled nitric oxide in children with severe asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012


Glucocorticoid treatment reduces exhaled nitric oxide in cystic fibrosis patients
Source: Eur Respir J 2001; 17: 1267-1270
Year: 2001



The effect of inhaled steroids on exhaled nitric oxide levels in children with idiopathic bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 181s
Year: 2001

Fractional exhaled nitric oxide in bronchiectasis
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012


Exhaled nitric oxide increases in chronic eosinophilic pneumonia
Source: Eur Respir J 2002; 20: Suppl. 38, 509s
Year: 2002

Exhaled nitric oxide and pulmonary function tests in children with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 759s
Year: 2007

Evaluation of exhaled nitric oxide in idiopathic interstitial lung diseases
Source: International Congress 2015 – IIPs: orphan
Year: 2015


Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments
Source: Eur Respir J 2009; 34: 117-124
Year: 2009